FdaApplication
NDA 210864
Identifiers
- fda_app_no: NDA210864
Properties
| Property | Value |
|---|---|
| applicant_name | LUPIN INC |
| application_type | NDA |
| approval_date | 2020-11-05 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SESQUIENT | FOSPHENYTOIN SODIUM | EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) | SOLUTION;INTRAVENOUS |
| SESQUIENT | FOSPHENYTOIN SODIUM | EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) | SOLUTION;INTRAVENOUS |
2 products